Ole Vahlgren
Vorstandsvorsitzender bei Aj Vaccines A/S
Vermögen: 552 428 $ am 31.05.2024
Aktive Positionen von Ole Vahlgren
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Go-PEN Aps
 Go-PEN Aps Medical SpecialtiesHealth Technology Go-Pen ApS develops insulin pen. The Danish company was founded in 2019 by Ole Kjerkegaard Nielsen, Michael Ejstrup Hansen. Ole Kjerkegaard Nielsen has been the CEO since 2019. | Direktor/Vorstandsmitglied | - | - |
Aj Vaccines A/S
 Aj Vaccines A/S BiotechnologyHealth Technology Part of AJ Biologics Sdn. The company is based in Copenhagen, Denmark. Bhd., AJ Vaccines A/S is a Danish pharmaceutical company that develops and manufactures vaccines against serious infectious diseases, as well as diagnostic and therapeutic solutions. The CEO of the company is Ole Vahlgren. | Vorstandsvorsitzender | - | - |
| Blue Cell Therapeutics ApS | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Ole Vahlgren
Ehemalige bekannte Positionen von Ole Vahlgren
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CAMURUS AB | Direktor/Vorstandsmitglied | 07.05.2020 | 08.05.2024 |
Otsuka Pharmaceutical Europe Ltd.
 Otsuka Pharmaceutical Europe Ltd. Medical DistributorsDistribution Services Otsuka Pharmaceutical Europe Ltd. markets drugs, nutraceuticals and other health care products manufactured by its Japan-based parent, Otsuka Pharmaceutical. Some of the company's nutraceutical products include Pocari Sweat-electrolyte replacement beverages, Calorie Mate-energy beverages and the Calcium. Otsuka also makes products for infants under the Bean Stalk name. Additionally, the company conducts pharmaceutical research focusing on gastroenterology, oncology, dermatology, ophthalmology and the cardiovascular system. The company was founded in 1998 and is headquartered in Uxbridge, UK | Vorstandsvorsitzender | - | - |
| Präsident | - | - |
Ausbildung von Ole Vahlgren
| Copenhagen Business School | Masters Business Admin |
| Technical University of Denmark | Graduate Degree |
Statistik
International
| Dänemark | 6 |
| Vereinigtes Königreich | 2 |
| Schweden | 2 |
Operativ
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| President | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CAMURUS AB | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Otsuka Pharmaceutical Europe Ltd.
Otsuka Pharmaceutical Europe Ltd. Medical DistributorsDistribution Services Otsuka Pharmaceutical Europe Ltd. markets drugs, nutraceuticals and other health care products manufactured by its Japan-based parent, Otsuka Pharmaceutical. Some of the company's nutraceutical products include Pocari Sweat-electrolyte replacement beverages, Calorie Mate-energy beverages and the Calcium. Otsuka also makes products for infants under the Bean Stalk name. Additionally, the company conducts pharmaceutical research focusing on gastroenterology, oncology, dermatology, ophthalmology and the cardiovascular system. The company was founded in 1998 and is headquartered in Uxbridge, UK | Distribution Services |
Go-PEN Aps
Go-PEN Aps Medical SpecialtiesHealth Technology Go-Pen ApS develops insulin pen. The Danish company was founded in 2019 by Ole Kjerkegaard Nielsen, Michael Ejstrup Hansen. Ole Kjerkegaard Nielsen has been the CEO since 2019. | Health Technology |
Aj Vaccines A/S
Aj Vaccines A/S BiotechnologyHealth Technology Part of AJ Biologics Sdn. The company is based in Copenhagen, Denmark. Bhd., AJ Vaccines A/S is a Danish pharmaceutical company that develops and manufactures vaccines against serious infectious diseases, as well as diagnostic and therapeutic solutions. The CEO of the company is Ole Vahlgren. | Health Technology |
| Blue Cell Therapeutics ApS |
- Börse
- Insiders
- Ole Vahlgren
- Erfahrung
